BTAI vs UHS · rev $388.0K vs P/E 5.9, rev $9.13B
BioXcel Therapeutics Inc (BTAI) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
BTAI currently screens at market cap $36.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the BTAI and UHS stock pages for the full models.
Not investment advice.